$71 Million is the total value of HealthInvest Partners AB's 13 reported holdings in Q4 2021. The portfolio turnover from Q3 2021 to Q4 2021 was 35.3% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| IRWD | Buy | IRONWOOD PHARMACEUTICALS INC | $8,512,000 | -4.9% | 730,000 | +6.6% | 11.99% | -10.5% |
| MCK | Buy | MCKESSON CORP | $8,451,000 | +429.8% | 34,000 | +325.0% | 11.91% | +398.5% |
| HRMY | Buy | HARMONY BIOSCIENCES HLDGS IN | $8,315,000 | +17.3% | 195,000 | +5.4% | 11.72% | +10.3% |
| ABBV | Buy | ABBVIE INC | $6,499,000 | +301.7% | 48,000 | +220.0% | 9.16% | +278.0% |
| CAH | Buy | CARDINAL HEALTH INC | $6,436,000 | +306.6% | 125,000 | +290.6% | 9.07% | +282.5% |
| ABC | Buy | AMERISOURCEBERGEN CORP | $6,379,000 | +281.5% | 48,000 | +242.9% | 8.99% | +259.0% |
| BMY | Buy | BRISTOL-MYERS SQUIBB CO | $6,235,000 | +276.3% | 100,000 | +257.1% | 8.79% | +254.0% |
| UTMD | Sell | UTAH MED PRODS INC | $4,000,000 | +2.6% | 40,000 | -4.8% | 5.64% | -3.5% |
| LJPC | Buy | LA JOLLA PHARMACEUTICAL CO | $3,860,000 | +258.4% | 830,000 | +207.4% | 5.44% | +237.2% |
| LCI | Buy | LANNET INC | $3,240,000 | -39.2% | 2,000,000 | +12.7% | 4.57% | -42.8% |
| ZGNX | Sell | ZOGENIX INC | $3,169,000 | -5.2% | 195,000 | -11.4% | 4.47% | -10.8% |
| ICPT | New | INTERCEPT PHARMACEUTICALS IN | $2,981,000 | – | 183,000 | +100.0% | 4.20% | – |
| RIGL | Sell | RIGEL PHARMACEUTICALS INC | $2,889,000 | -54.9% | 1,090,000 | -38.2% | 4.07% | -57.6% |
| URGN | Exit | UROGEN PHARMA LTD | $0 | – | -75,000 | -100.0% | -1.89% | – |
| EOLS | Exit | EVOLUS INC | $0 | – | -300,000 | -100.0% | -3.42% | – |
| ALDX | Exit | ALDEYRA THERAPEUTICS INC | $0 | – | -310,000 | -100.0% | -4.08% | – |
| ARAY | Exit | ACCURAY INC | $0 | – | -1,860,000 | -100.0% | -11.00% | – |
| SUPN | Exit | SUPERNUS PHARMACEUTICALS INC | $0 | – | -335,000 | -100.0% | -13.38% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-01-18
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| CHARLES RIV LABS INTL INC | 17 | Q4 2017 | 12.8% |
| GILEAD SCIENCES INC | 16 | Q4 2022 | 14.5% |
| CARDINAL HEALTH INC | 15 | Q4 2022 | 14.8% |
| IMMUCELL CORP | 15 | Q2 2017 | 1.7% |
| MCKESSON CORP | 14 | Q3 2022 | 14.6% |
| ANTHEM INC | 12 | Q4 2017 | 14.3% |
| TRIPLE-S MGMT CORP | 12 | Q4 2016 | 8.7% |
| LIFEPOINT HOSPITALS INC | 11 | Q2 2016 | 13.3% |
| SUPERNUS PHARMACEUTICALS INC | 10 | Q3 2021 | 15.5% |
| ANIKA THERAPEUTICS INC | 10 | Q4 2017 | 13.0% |
View HealthInvest Partners AB's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| NOVAMED INC | March 03, 2011 | 405,875 | 5.1% |
| THERAGENICS CORP | February 11, 2009 | 3,322,846 | 9.9% |
| BIO IMAGING TECHNOLOGIES INC | January 09, 2009 | 766,425 | 5.3% |
| ALLION HEALTHCARE INC | July 07, 2008 | 887,255 | 4.6% |
| SONIC INNOVATIONS INC | June 26, 2008 | 1,328,201 | 4.9% |
| CANDELA CORP /DE/ | June 06, 2008 | 697,164 | 3.1% |
| INTEGRAMED AMERICA INC | June 02, 2008 | 2,200 | 0.0% |
| AFP IMAGING CORP | February 04, 2008 | 27,520 | 0.2% |
| OPHTHALMIC IMAGING SYSTEMS | December 28, 2007 | 834,440 | 4.9% |
| ANGEION CORP/MN | October 16, 2007 | 196,024 | 4.8% |
View HealthInvest Partners AB's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-01-30 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-10-21 |
| 13F-HR | 2022-07-08 |
| 13F-HR | 2022-05-05 |
| 13F-HR | 2022-01-18 |
| 13F-HR | 2021-11-08 |
| 13F-HR | 2021-08-10 |
| 13F-HR | 2021-04-30 |
| 13F-HR | 2021-02-05 |
View HealthInvest Partners AB's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.